Back to mobile site
Get it on Google Play

Immunic presents MS drug data at Toronto neurology conference

October 21, 2026 7:01 AM EDT Send to a Friend
Immunic, Inc. (Nasdaq: IMUX) presented clinical, biomarker, and preclinical data for its investigational drug vidofludimus calcium (IMU-838) across four poster ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login